Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс: http://elar.urfu.ru/handle/10995/96909
Название: How zebrafish models are reshaping modern translational neuroscience and drug discovery research
Авторы: Kalueff, A. V.
Khatsko, S. L.
Zabegalov, K. N.
Zhdanov, A. V.
Дата публикации: 2020
Издатель: Издательство АМБ
Библиографическое описание: How zebrafish models are reshaping modern translational neuroscience and drug discovery research / A. V. Kalueff, S. L. Khatsko, K. N. Zabegalov, A. V. Zhdanov // Актуальные вопросы органической химии и биотехнологии : материалы очных докладов международной научной конференции (Екатеринбург, 18–21 ноября 2020 г.). — Екатеринбург : Издательство АМБ, 2020. — С. 37-38.
Аннотация: The zebrafish (Danio rerio) is a small freshwater teleost fish that has become a new powerful aquatic vertebrate model organism in preclinical biomedical research and drug screening. Zebrafish possess all major neurotransmitter receptors, transporters and enzymes, as well as express rich behavioral repertoire, thereby offering a wide spectrum of CNS disease models. However, our understanding of zebrafish role as a new emerging mainstream model in neuroscience research is still limited. For example, zebrafish behavior has long been mistakenly viewed as “primitive” or “reflex-driven”, resulting in incomplete utilization of the major advantages of this species for CNS disease modeling or drug discovery – 1) phenotypic robustness, 2) ease of experimental manipulations, 3) high-throughput potential, and 4) high relevance to the 3Rs principles of humane animal experimentation. Here, we will discuss zebrafish models relevant to several important human disorders, including epilepsy, autism, stress/depression, anxiety and addiction, to demonstrate excellent future of this model organism in biological psychiatry research. Furthermore, zebrafish are highly sensitive to all major classes of neurotropic drugs (including antipsychotics, anxiolytics, antidepressants, sedatives/anesthetics, stimulants, hallucinogens, antiepileptics) and are well-suited to various high-throughput applications (due to their high fecundity, rapid external development, transparency, fast drug intake, and robust behavioral and physiological phenotypes in both larval and adult fish). Finally, zebrafish emerge as an excellent model for neurogenetic analyses, as they have 25 pairs of chromosomes containing 26,000 protein-coding genes, with the overall genetic homology to mammals and humans around 75 %, and nearly 85 % of shared genes known to be associated with human disease. Collectively, this calls for a wider use of zebrafish models as a powerful promising model organism for neuroscience and drug discovery research.
Ключевые слова: ZEBRAFISH
NEUROSCIENCE
DRUG SCREENING
URI: http://elar.urfu.ru/handle/10995/96909
Конференция/семинар: Международная научно-практическая конференция «Актуальные вопросы органической химии и биотехнологии»
International Scientific Conference “Actual Problems of Organic Chemistry and Biotechnology”
Дата конференции/семинара: 18.11.2020-21.11.2020
ISBN: 978-5-6045430-2-3
Сведения о поддержке: This study was supported by the Russian Science Foundation RSF grant 19‐15‐00053.
Карточка проекта РНФ: 19-15-00053
Источники: Актуальные вопросы органической химии и биотехнологии. — Екатеринбург, 2020
Располагается в коллекциях:Конференции, семинары

Файлы этого ресурса:
Файл Описание РазмерФормат 
978-5-6045430-2-3_2020_006.pdf387,25 kBAdobe PDFПросмотреть/Открыть


Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.